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During the postpartum period, women are at risk for new onset of both auto-immune thyroid 
disorders and depression. The presence of thyroid peroxidase antibodies (TPO-ab) during 
early gestation is predictive for postpartum auto-immune thyroid dysfunction. The aim of this 
study was to investigate the association between TPO-ab status during early gestation and 
first-onset postpartum depression. 
 
Methods:  
Prospective cohort study (n=1075) with follow-up during pregnancy up to one year 
postpartum. Thyroid function and TPO-ab status were measured during early gestation. 
Depressive symptomatology was assessed during each trimester and at four time points 
postpartum with the Edinburgh Depression Scale (EDS). Women with antenatal depression 
were not eligible for inclusion. Self-reported postpartum depression was defined with an EDS 
cut-off of ≥13. 
 
Results:  
The cumulative incidence of self-reported first-onset depression in the first postpartum year 
was 6.3%. A positive TPO-ab status was associated with an increased risk for self-reported 
first-onset depression at four months postpartum (adjusted OR 3.8; 95% CI 1.3-11.6), but not 
at other postpartum time points. Prevalence rates of self-reported postpartum depression 
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declined after four months postpartum in the TPO-ab positive group, but remained constant in 
the TPO-ab negative group.  
 
Limitations:  
Depression was defined with a self-rating questionnaire (EDS). 
 
Conclusions:  
Women with an increased TPO-ab titer during early gestation are at increased risk for self-
reported first-onset depression. The longitudinal pattern of self-reported postpartum 
depression in the TPO-ab positive group was similar to the typical course of postpartum TPO-
ab titers changes. This suggests overlap in the etiology of first-onset postpartum depression 
and auto-immune thyroid dysfunction. Thyroid function should be evaluated in women with 
first-onset postpartum depression.  
 
Keywords: TPO-ab; pregnancy; postpartum depression; EDS; onset timing; thyroid 
dysfunction 
Introduction 
Postpartum depression is a disabling and heterogeneous disorder with a huge variety in 
biological, psychological and social risk factors (Howard et al., 2014). In addition, there is 
substantial difference in the onset timing, severity and course of postpartum depression 
(Putnam et al., 2017) (Fisher et al., 2016). The most important risk factor for postpartum 
depression is a depressive episode earlier in life or during pregnancy. In a large study among 
women with postpartum depression, approximately 60% of women reported an onset of their 
episode before pregnancy or during the antenatal period (Wisner et al., 2013). 
 Antenatal depression occurs during an entirely different immune and endocrine state 
than postpartum depression and may therefore have a different origin (Osborne and Monk, 
2013). Interestingly, the postpartum period is a high risk period for more severe and first-
onset episodes of depression (Munk-Olsen et al., 2016). Therefore, it is important to consider 
onset timing when studying risk factors for postpartum depression (Wisner et al., 2013). 
 The postpartum period is also associated with an increased risk for the new onset of 
auto-immune thyroid disorders (Andersen et al., 2016). The presence of thyroid peroxidase 
antibodies (TPO-ab) during early gestation is a clear marker for the occurrence of postpartum 
auto-immune thyroid dysfunction, induced by the typical postpartum rebound phenomena of 
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TPO-ab titers (Balucan et al., 2013; Fung et al., 1988; Jansson et al., 1984; Stagnaro-Green et 
al., 1992). Interestingly, TPO has also been named as a predictor for postpartum depression 
(Dama et al., 2016). 
 Four studies reported an association between an increased TPO-ab titer during early 
gestation and depression postpartum (Groer and Vaughan, 2013; Harris et al., 1992; Kuijpens 
et al., 2001; Lazarus et al., 1996). However, none of these studies focused on first-onset 
depression and three out of four studies did not take into account antenatal depression (Groer 
and Vaughan, 2013; Harris et al., 1992; Lazarus et al., 1996), while one study only briefly 
mentioned this in a sub analysis (Kuijpens et al., 2001). Together, as acknowledged by Dama 
and colleagues in their recent review, in previous studies antenatal depression may have 
confounded the association between a TPO-ab positive status during pregnancy and 
postpartum depression (Dama et al., 2016). Accordingly, the current study was designed to 
investigate the association between a positive TPO-ab status during early gestation and first-
onset postpartum depression. We hypothesized that women are particularly at increased risk 





Participants were included in the Holistic Approach to Pregnancy and the first Postpartum 
year (HAPPY) study, a large prospective cohort that is described in detail elsewhere (Truijens 
et al., 2014). In sum, the HAPPY-study focuses on maternal wellbeing during pregnancy and 
the postpartum period. During a recruitment period of 18 months (2013-2014), Dutch-
speaking pregnant women were informed about the study during their first trimester 
appointment at 17 community midwives offices in the South-East of the Netherlands. Women 
with a non-singleton pregnancy or history of a severe psychiatric disorder were not eligible 
for inclusion. We excluded women with a self-reported lifetime history of depression as well 
as all women with depression during the full course of their pregnancy. In addition, women 
with a known thyroid disease at baseline as well as other endocrine/auto-immune disorders 
were not eligible for inclusion. The HAPPY-study was approved by the Medical Ethical 
Committee of the Maxima Medical Centre Veldhoven and the Psychology Ethics Committee 




Data collection, procedures and definitions 
This study is reported in line with the STROBE guidelines (von Elm et al., 2007). 
Questionnaires were used to collect baseline demographic information, as well as relevant 
medical, obstetric, psychological and lifestyle data. If applicable, data were verified with 
medical records. Standardized blood measurements were performed at 10-12 weeks gestation 
and included TPO-ab, as well as thyroid releasing hormone (TSH) and free thyroxine (FT4). 
Measurements were performed in Li-heparin plasma using electrochemoluminescence assays 
(Cobas® e 601, Roche Diagnostics, Mannheim Germany). We defined a positive TPO-ab 
status with the commonly used threshold of >20 IU/ml (Prummel and Wiersinga, 2005). This 
cut-off is probably not appropriate throughout the full course of pregnancy (Dama et al., 
2016). Therefore, we performed the TPO-ab measurement during early pregnancy, before 
downsizing of maternal auto-immune processes emerges (Balucan et al., 2013). 
 Depressive symptomatology was assessed repeatedly every trimester and four times 
during the postpartum period (6 weeks, and 4, 8, and 12 months) using the Edinburgh 
Depression Scale (EDS). The EDS is validated to detect women with a high probability of 
major depression both during pregnancy and postpartum. In this study, self-reported 
depression was defined with the following validated EDS cut-off scores: trimester 1, ≥11; 
trimester 2 and 3, ≥10; (Bergink et al., 2011); postpartum period ≥13 (Cox et al., 1987; Harris 
et al., 1989; Pop et al., 1992). Women who scored above the trimester cut-offs during the 
course of their pregnancy were not eligible for inclusion in our study.  
 Our primary outcome measure was the occurrence of first-onset self-reported 
depression (i.e. incidence of new cases) at four months postpartum. Women with an increased 
TPO-ab titer during early gestation show a subsequent decline of their titer throughout 
pregnancy, with a typically rebound between three to five months postpartum and a gradual 
decline afterwards (Fung et al., 1988; Jansson et al., 1984; Stagnaro-Green et al., 1992). 
Therefore we considered four months postpartum to be the most optimal time point available 
to assess a possible association between a positive TPO-ab status during early gestation and 
the occurrence of first-onset self-reported depression postpartum. First-onset self-reported 
depression at other postpartum time points (6 weeks, 8 and 12 months) were used as 








SPSS (version 24, IBM) was used for the statistical analyses. Binary logistic regression was 
used to evaluate the association between TPO-ab status during the first trimester (exposure) 
and the incidence of new cases of self-reported depression at four months postpartum 
(primary outcome), and at 6 weeks, 8 months and 12 months postpartum (secondary 
outcomes). To facilitate interpretation of the results, we plotted point prevalence rates of self-
reported postpartum depression (EDS ≥13) over time (at 6 weeks, 4, 8 and 12 months 
postpartum) according to TPO-status. A multiple logistic regression analysis was performed 
to adjust for potential confounders. Based on previous literature, we included the following 
confounding variables: anxiety during pregnancy (Generalized Anxiety Disorder (GAD-7) 
scale sum score at 12 weeks gestation, continuous), age (years, continuous) and preterm 
delivery (<37 weeks of gestation, dichotomous) (Dama et al., 2016), primiparity 
(dichotomous) (Greer et al., 2011; Howard et al., 2014) and recent life-events (self-reported, 
dichotomous) (Kuijpens et al., 2001). In addition, we considered the following confounding 
variables: mode of delivery (vaginal delivery or cesarean section), health problems of the 
baby (self-reported, dichotomous) and social support during the postpartum period (Tilburg 
Support Scale sum score, continuous). All potential confounding variables were introduced 
both separately and simultaneously into the unadjusted model to verify a potential effect on 
our exposure of interest (TPO-ab status). Logistic regression analyses were evaluated with 
Wald tests (χ
2
, distribution, α=0.05). Results are presented with crude and adjusted odds 
ratio’s (OR’s) together with corresponding 95% confidence intervals. 
 Additionally, we tested whether a positive TPO-ab status during pregnancy was 
associated with differences in mean TSH and FT4 concentrations by using T-tests. TSH data 
was log-transformed to meet the assumption of normality, and log transformed mean TSH 
values are reported. Cohen’s d are used to report the size of the effect (Cohen, 1988). Finally, 
we used a sensitivity analysis to assess the robustness of the findings. For this aim, we 
changed the dichotomous TPO-ab variable into a categorical variable (3 categories: ≤ 20 
IU/ml; 21-100 IU/ml; ≥101 IU/ml). 
 Women were included in the final study sample if 1) at least two out of three 
pregnancy EDS scores were available and 2) the EDS score at four months postpartum 
(primar outcome measure) was available.  
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 As a result of our data selection strategy we did not have any missing data on our 
primary outcome measure (EDS score ≥13 at 4 months postpartum). During pregnancy, the 
proportion of missing EDS measures varied between 1.7% to 2.5%. Regarding the secondary 
outcome measures, the proportion of missing data varied between 8.3% to 23.3%. Missing 
data was handled with the multiple imputation algorithm as implemented in SPSS version 24 
(IBM). Ten imputed datasets were created and all predictor and outcome variables were used 
for imputation modelling. Analyses were run on the imputed data and pooled estimates are 
reported (Rubin, 2008). To explore the impact of the imputation procedure on our results, we 




A detailed overview of the participant selection process is presented in Figure 1. In total, 
n=3160 Dutch-speaking pregnant women were informed about the HAPPY-study, of which 
71.8% (n=2269) provided informed consent. A self-reported lifetime history of depression 
(n=300) and on ore more EDS scores above the trimester specific cut-offs during pregnancy 
(n=386) were the most important reasons for exclusion. Of the women that were eligible for 
this study (n=1364), follow-up data at four months postpartum was available for n=1075 
(78.8%) women. According to the baseline demographic study characteristics (Table 1), the 
vast majority of women had the Dutch nationality, a high educational level, a paid job and 
was married or living together. Most baseline characteristics did not differ substantially 
between women that were included and excluded because of missing follow-up data during 
pregnancy or at four months postpartum (n=289, 21.2%). However, excluded women showed 
a higher prevalence of unplanned pregnancies (7.8% versus 3.7%), preterm delivery (6.6% 
versus 3.5%), smoking during pregnancy (8.6% versus 2.6%) and a lower prevalence of high 
education level (50.8% versus 69.3%). 
 
TABLE 1. Baseline characteristics (n=1075) 
 mean (SD) n (%) 
Age (years) 30.4 (3.5)  
Gestational age (days)  278 (10)  
7 
 
Preterm delivery (<37 weeks)  38 (3.5) 
Married or living together  1044 (99.0) 
High educational level
b  764 (69.3) 
Dutch nationality  1038 (98.4) 
Paid job  1014 (96.2) 
Primiparous  525 (49.9) 
Unplanned pregnancy  39 (3.7) 
Smoking during pregnancy  27 (2.6) 
Alcohol consumption during 
pregnancy 
 13 (1.2) 
a 
In case of missing data (maximum n=22), valid percentages are presented 
b 
Bachelor and/or master degree 
 
 
Thyroid measurements and EDS scores during pregnancy 
In total, 121 out of 1075 women (11.3%) had a positive TPO-ab status (>20 IU/ml) at 12 
weeks of gestation. The median of the positive TPOA-ab measurements was 74.0 IU/ml, with 
an inter quartile range (IQR) of 29.0 – 170.0. In the full sample, we observed a median TSH 
blood level of 1.4 mU/L (IQR 1.0-2.1 mU/l) and median FT4 of 14.4 pmol;/L (IQR 13.4-15.4 
pmol;/L).  
 TSH concentrations were significantly higher in the group with a positive TPO-AB 
status (log-transformed mean 0.3 mU/L, SD 0.4) compared to the group with a negative TPO-
ab status (log-transformed mean 0.1 mU/L, SD 0.3); t(1073) = -4.9, p<0.0001, cohen’s 
d=0.43, medium effect size). FT4 concentrations were significantly lower in the group with a 
positive TPO-AB status (mean 14.2 pmol/L, SD 1.8) than in de group with a negative TPO-ab 
status (mean 14.6 pmol/L, SD 1.7; t(1073)=2.2, p=0.028, Cohen’s d=0.23, small effect size). 
 We excluded women with an EDS score above the trimester specific cut-offs, which 
resulted in the following mean EDS scores of the remaining women: trimester 1, 2.7 (SD 2.5); 
trimester 2, 3.4 (SD 2.6); trimester 3, 3.3 (SD 2.6). Mean EDS-scores did not significantly 





The association between thyroid peroxidase antibodies status and first-onset postpartum 
depression 
In the total sample, 6.3% (68/1075) of the women fulfilled the definition of self-reported 
postpartum depression at one or more of the four assessments during the first postpartum year 
(n=43 once; n=16 twice; n=6 three times; n=3 four times).  
 At four months postpartum, we observed a risk of self-reported first-onset postpartum 
depression of 5.0% (6/119) among women with a positive TPO-ab status, compared to 1.5% 
(14/934) among women with a TPO-ab negative status (crude OR 3.5, 95% CI 1.3–9.4, 
p=0.016). This effect remained significant after adjustment for potential confounders (see 
method section) (adjusted OR 3.8, 95% CI 1.3-11.6, p=0.017). 
 The association between TPO-ab status and self-reported first-onset depression was 
not significant at 6 weeks, 8 months and 12 months postpartum. The point prevalence rates of 
self-reported postpartum depression according to TPO-ab status at all postpartum assessments 
are presented in Figure 2. After a peak of self-reported postpartum depression at four months 
postpartum among women with a positive TPO-ab status, the point prevalence rates of self-
reported postpartum depression linearly declined from 5.8% (7/121) to 0.8% (1/121) at 12 
months postpartum. Among women with a negative TPO-ab status, the prevalence rates of 
self-reported postpartum depression remained relatively constant across all time points in the 
first postpartum year (2.1%, 20/954 – 3.0%, 29/954). A sensitivity analysis showed that 
the direction of the association between TPO-ab and self-reported first-onset depression at 
four months postpartum remained constant after changing our dichotomous exposure TPO-ab 
status into a categorical covariate (≤ 20 IU/ml; 21-100 IU/ml; ≥101 IU/ml). Repeating the 
analyses in the original (non-imputed) dataset supported our findings regarding the direction, 
size and significance of the reported associations. 
Discussion 
In this large prospective cohort study including n=1075 women, the cumulative incidence of 
self-reported first-onset postpartum depression during the first postpartum year was 6.3%.      
A positive TPO-ab status during pregnancy was associated with a threefold increased risk of 
self-reported first-onset depression at four months postpartum but not at other postpartum 
time points. Point prevalence rates of self-reported postpartum depression declined after four 
months postpartum among women with a TPO-ab positive status, but remained constant 
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among women with a TPO-ab negative status throughout the first postpartum year. These 
findings suggest a link between the typical postpartum rebound phenomena of the maternal 
immune system and first-onset postpartum depression. 
 Previous studies reported a substantially higher overall risk for postpartum depression 
(i.e. regardless of TPO-abs status). For example, in the study of Harris and colleagues (Harris 
et al., 1992), 27.3% (66/242) of the women had an EDS score ≥13. In the study of Kuijpens 
and colleagues (Kuijpens et al., 2001), an even higher proportion of women (117/291, 40.2%) 
was classified with a clinical diagnosis of postpartum depression during one or more 
assessments (according to the RDC-criteria). This is probably due to the high proportion of 
women with depression in history or depression during pregnancy. In the same study, the 
association between an increased TPO-ab titer at 12 weeks gestation and postpartum 
depression remained significant after exclusion of women with an episode of depression 
earlier in life and/or at 12 weeks gestation (sub-analysis (n=191), OR 2.9, 95% CI 1.8-4.3). 
This is in in line with the odds ratio that we observed at four months postpartum (OR 3.8, 
95% CI 1.3-11.6). However, in contrast to our study, Kuijpens et al. did not focus on first-
onset depression since women with depression during the second and/or third trimester were 
not excluded. In addition, the onset timing of postpartum depression was not reported. Our 
study was not confounded by antenatal depression and we could therefore show evidence for 
a causal link between the new occurrence of thyroid autoimmunity and depression 
postpartum. 
 There is accumulating evidence that immune system dysregulation is one of the 
underlying biological mechanisms that play an important role in the etiology of depression 
(Miller et al., 2009; Osborne and Monk, 2013). A mechanism that may be specifically related 
to first-onset postpartum depression, is the shift from immune tolerance during pregnancy 
towards a pro-inflammatory state during the postpartum period (Corwin et al., 2015; Osborne 
and Monk, 2013). Interestingly, self-reported postpartum depression prevalence rates of the 
women with a positive TPO-ab status showed a pattern that is similar to the typical course of 
postpartum TPO-ab titers (Feldt-Rasmussen et al., 1990; Fung et al., 1988; Jansson et al., 
1984; Stagnaro-Green et al., 1992): particular highly increased levels during the early (four 
months) postpartum period and a subsequent decrease (but still above the threshold) up to one 
year postpartum.  
 There is a well described link between the postpartum rebound of TPO-ab titers and 
clinical thyroid dysfunction (Lazarus et al., 2002). Consequently, among women with a 
positive TPO-ab status during pregnancy, first-onset postpartum depression may be related to 
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a transient hypothyroid phase of postpartum thyroid dysfunction (Stagnaro-Green, 2002). 
Interestingly, the results of a previous study from Harris and colleagues (Harris et al., 1992) 
revealed that a positive TPO-ab status postpartum was predictive for an increase in depressive 
symptomatology postpartum, regardless of the presence of thyroid dysfunction. An 
explanation for this phenomenon could be that immune activation postpartum leads to 
increased risk of depression instead of clinical thyroid dysfunction. Interestingly, a 
disturbance in the suppression and activation of several T-cell subpopulations have been 
associated with both increased TPO-ab titers and psychiatric disorders (Bergink et al., 2013; 
Drexhage et al., 2011a; Drexhage et al., 2011b; Lazarus et al., 2002). Therefore, T-cell 
abnormalities may also play a shared role in the etiology of postpartum depression and 
postpartum thyroid dysfunction.  
 
Clinical considerations 
The postpartum period is known to be a trigger for first-onset psychiatric disorders (Munk-
Olsen et al., 2016). In this study we were able to identify a new risk factor for the occurrence 
of self-reported first-onset postpartum depression at four months postpartum. The findings of 
the current study support the general statement that the etiology of postpartum depression is 
multifactorial. There seems to be a sub-group of women (especially during the first four 
months) in whom thyroid auto-immunity plays a role in the development of depressive 
symptomatology. We follow the view that thyroid function should be evaluated during the 
postpartum period if women present with first time depressive symptomatology. Measurement 
of thyroid-stimulating hormone is a first diagnostic step for the detection of thyroid 
dysfunction. 
 Another clinical consideration is the increased risk for women with increased TPO-ab 
titers for both thyroid dysfunction (particularly hypothyroidism) and depression later in life 
(Balucan et al., 2013; Pop et al., 1998; Vanderpump et al., 1995) The risk for hypothyroidism 
is especially high for women with both increased TPO-ab titers and TSH concentrations, even 
if TSH concentrations are still within the normal range (Prummel and Wiersinga, 2005; 
Vanderpump et al., 1995).  
 
Strengths, limitations and directions for future research 
To our knowledge, this is the first study that evaluated the association between TPO-ab titers 
during early gestation and (self-reported) first-onset postpartum depressive episodes. We 
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included a large number of women and adjusted for potential confounders. However, our 
study also has several limitations. First, we did not assess TPO-ab titers, thyroid function and 
immune system parameters during the postpartum period. Consequently, it is unknown, to 
what extend thyroid dysfunction and immune system dysregulation was present among 
women with self-reported first-onset postpartum depression. Second, we used a self-rating 
questionnaire (EDS) to define depression. Therefore, it is unclear which proportion of the 
women with an EDS above the cut-off in our sample would fulfill the criteria of a clinically 
established diagnosis of postpartum depression. Third, we were not able to adjust for the 
presence of sexual child-abuse, which is a potential confounder of the studied association 
(Plaza et al., 2012). Finally, the findings of our study are not generalizable to women with a 
psychiatric history and/or women with antenatal depression, because we designed our study to 
investigate first-onset episodes of depression. Future studies on first-onset depression should 
also include longitudinal assessments of thyroid function (including TPO-ab titers) and 
immune system parameters (e.g. screening for potential abnormalities in T-cell 
subpopulations) during the postpartum period. This strategy will be helpful to further 
understand the role of immune system dysregulation in first-onset postpartum depression.  
 
Conclusions 
In this large prospective cohort study, we demonstrated that women with a positive TPO-ab 
status during early gestation are at increased risk for self-reported first-onset depression at 
four months postpartum. This period coincides with the typical postpartum rebound 
phenomena of the maternal immune system, which suggests an overlap in the etiology of first-
onset postpartum depression and auto-immune thyroid dysfunction. Evaluation of thyroid 
function is essential in the clinical assessment of first-onset postpartum depression. 
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Fig. 2 point prevalence rates of postpartum depression (EDS13) across the first postpartum year according to 
TPO-ab status during pregnancy (n=1075) 
 
Highlights 
•  The postpartum period triggers the new onset of both thyroid disorders and depression 
• A positive TPO-ab status during pregnancy was associated with first-onset postpartum 
depression 
• Thyroid function evaluation is essential in women with first-onset postpartum depression 
 
 
